Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report
Abstract Hyperprogressive disease (HPD) is a novel progressive pattern that occurs after immune checkpoint inhibitor (ICI) administration. Here, a 74‐year‐old woman who had undergone right lower lobectomy for lung cancer received curative chemoradiotherapy followed by consolidation therapy with durv...
Збережено в:
| Автори: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2023-11-01
|
| Серія: | Thoracic Cancer |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1111/1759-7714.15104 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|